William P. Phelan - Jan 14, 2022 Form 4/A - Amendment Insider Report for Soluna Holdings, Inc (SLNH)

Role: Director
Signature: /s/ Christopher Gandolfo, Attorney in Fact
Stock symbol: SLNH
Transactions as of: Jan 14, 2022
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 8/25/2022, 04:18 PM
Date Of Original Report: Jan 19, 2022
Previous filing: May 17, 2021
Next filing: Aug 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SLNH	Common Stock	Award	$0	+60.5K	+24.72%	$0.00	305K	Jan 14, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction reported is a grant of 20,500 and 40,000 restricted stock units representing shares (the "2022 Grant") of common stock, par value $0.001 per share, of the issuer (the "Common Stock") received as compensation for the reporting person's service as a member of the issuer's board of directors and as chairman of the board of directors, respectively. The shares of Common Stock subject to the 2022 Grant vest as follows: 37% vests 12 months from the date of the grant, or January 14, 2023, 33% vests 24 months from the date of the grant, or January 14, 2024, and 30% vests 36 months from the date of the grant, or January 14, 2025, in each case subject to the reporting person remaining in the service of the issuer on each such vesting date.
F2	This corrects Mr. Phelan's Form 4 filed on January 19, 2022, which inadvertently reported the incorrect number of beneficial ownership shares of common stock due to a typographical error. The correct number of securities acquired was reported in Column 4.

Content

Transaction reported is a grant of 20,500 and 40,000 restricted stock units representing shares (the "2022 Grant") of common stock, par value $0.001 per share, of the issuer (the "Common Stock") received as compensation for the reporting person's service as a member of the issuer's board of directors and as chairman of the board of directors, respectively. The shares of Common Stock subject to the 2022 Grant vest as follows: 37% vests 12 months from the date of the grant, or January 14, 2023, 33% vests 24 months from the date of the grant, or January 14, 2024, and 30% vests 36 months from the date of the grant, or January 14, 2025, in each case subject to the reporting person remaining in the service of the issuer on each such vesting date.

This corrects Mr. Phelan's Form 4 filed on January 19, 2022, which inadvertently reported the incorrect number of beneficial ownership shares of common stock due to a typographical error. The correct number of securities acquired was reported in Column 4.